Sivik Global Healthcare LLC Buys 6,600 Shares of Encompass Health Corporation (NYSE:EHC)

Sivik Global Healthcare LLC raised its holdings in shares of Encompass Health Corporation (NYSE:EHC - Free Report) by 14.7% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 51,600 shares of the company's stock after purchasing an additional 6,600 shares during the period. Encompass Health comprises about 2.8% of Sivik Global Healthcare LLC's portfolio, making the stock its 19th largest holding. Sivik Global Healthcare LLC owned approximately 0.05% of Encompass Health worth $5,226,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of EHC. Colonial Trust Co SC bought a new position in shares of Encompass Health during the fourth quarter valued at approximately $29,000. Transce3nd LLC acquired a new position in shares of Encompass Health during the fourth quarter valued at $40,000. CBIZ Investment Advisory Services LLC increased its holdings in shares of Encompass Health by 38.7% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock worth $42,000 after acquiring an additional 127 shares during the period. Signaturefd LLC lifted its position in Encompass Health by 21.6% in the 4th quarter. Signaturefd LLC now owns 704 shares of the company's stock valued at $65,000 after purchasing an additional 125 shares during the last quarter. Finally, C M Bidwell & Associates Ltd. boosted its stake in Encompass Health by 73.6% during the 4th quarter. C M Bidwell & Associates Ltd. now owns 750 shares of the company's stock valued at $69,000 after purchasing an additional 318 shares during the period. 97.25% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts recently commented on EHC shares. UBS Group raised their target price on Encompass Health from $117.00 to $130.00 and gave the company a "buy" rating in a research report on Monday, April 28th. Stephens upgraded shares of Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 price objective on the stock in a research note on Thursday, June 5th. Wall Street Zen lowered shares of Encompass Health from a "strong-buy" rating to a "buy" rating in a research report on Friday, June 6th. Truist Financial reaffirmed a "buy" rating and issued a $135.00 price target (up from $116.00) on shares of Encompass Health in a research note on Monday, April 28th. Finally, KeyCorp lifted their price target on Encompass Health from $122.00 to $135.00 and gave the company an "overweight" rating in a research report on Tuesday, May 27th. Eight analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, Encompass Health currently has a consensus rating of "Buy" and an average price target of $127.00.

Insiders Place Their Bets

In other Encompass Health news, EVP John Patrick Darby sold 10,000 shares of Encompass Health stock in a transaction that occurred on Tuesday, April 29th. The stock was sold at an average price of $114.79, for a total value of $1,147,900.00. Following the transaction, the executive vice president now directly owns 79,710 shares of the company's stock, valued at $9,149,910.90. The trade was a 11.15% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Mark J. Tarr sold 118,384 shares of the firm's stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of $121.53, for a total transaction of $14,387,207.52. Following the completion of the sale, the chief executive officer now owns 527,070 shares in the company, valued at approximately $64,054,817.10. The trade was a 18.34% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 132,663 shares of company stock valued at $16,034,082 over the last three months. 2.10% of the stock is currently owned by insiders.

Encompass Health Stock Up 0.7%

Shares of EHC traded up $0.79 during mid-day trading on Tuesday, reaching $121.01. The company's stock had a trading volume of 575,010 shares, compared to its average volume of 703,100. Encompass Health Corporation has a 1 year low of $82.74 and a 1 year high of $123.13. The company has a market cap of $12.20 billion, a price-to-earnings ratio of 25.00, a price-to-earnings-growth ratio of 2.44 and a beta of 0.89. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.81. The business has a fifty day moving average of $116.14 and a 200 day moving average of $104.12.

Encompass Health (NYSE:EHC - Get Free Report) last posted its quarterly earnings results on Thursday, April 24th. The company reported $1.37 EPS for the quarter, beating the consensus estimate of $1.19 by $0.18. Encompass Health had a net margin of 8.97% and a return on equity of 17.63%. The business had revenue of $1.46 billion for the quarter, compared to analysts' expectations of $1.43 billion. During the same period in the previous year, the company posted $1.12 EPS. Encompass Health's revenue was up 10.6% on a year-over-year basis. As a group, analysts forecast that Encompass Health Corporation will post 4.8 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be paid a $0.17 dividend. This represents a $0.68 annualized dividend and a dividend yield of 0.56%. The ex-dividend date is Tuesday, July 1st. Encompass Health's payout ratio is presently 14.05%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.